Family Medicine · San Francisco, CA
NPI
1477943199
Since 2015
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
229 7th St
San Francisco, CA, 94103
Phone (415) 503-6000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$286K
2,986 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Eileen H Kim prescribed most often to Medicare patients was Atorvastatin Calcium, with 219 prescriptions and refills. In total Eileen H Kim wrote 2,986 Medicare prescriptions that cost $286K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 219 | 220 | 28 | $10K |
| Amlodipine Besylate Generic | 153 | 153 | 21 | $3,475 |
| Gabapentin Generic | 111 | 111 | 15 | $3,680 |
| Lisinopril Generic | 90 | 91 | 13 | $1,320 |
| Trazodone Hcl Generic | 76 | 76 | Under 11 | $1,439 |
| Levothyroxine Sodium Generic | 74 | 74 | Under 11 | $813 |
| Famotidine Generic | 66 | 69 | 13 | $2,845 |
| Hydrochlorothiazide Generic | 62 | 62 | Under 11 | $437 |
| Finasteride Generic | 62 | 62 | Under 11 | $1,910 |
| Losartan Potassium Generic | 57 | 57 | Under 11 | $1,342 |
| Fluticasone Propionate Generic | 56 | 67 | Under 11 | $1,826 |
| Metformin Hcl Generic | 55 | 55 | Under 11 | $1,442 |
| Tamsulosin Hcl Generic | 54 | 54 | Under 11 | $1,737 |
| Simvastatin Generic | 53 | 53 | Under 11 | $2,397 |
| Furosemide Generic | 53 | 54 | Under 11 | $439 |
Brand drugs: 485 claims; generic drugs: 2,480 claims; opioid claims: 53.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Eileen H Kim were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.